Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow

Autor:	Mats Ehinger, Gunnar Juliusson, Anna Lübking, Henrik Lilljebjörn, Marianne Rissler, Christina Orsmark-Pietras, Thoas Fioretos, Louise Pettersson, Vladimir Lazarevic
Rok vydání:	2018
Předmět:	0301 basic medicine Myeloid business.industry Immunology Myeloid leukemia Cell Biology Hematology medicine.disease Biochemistry World health NFE2 03 medical and health sciences 030104 developmental biology 0302 clinical medicine medicine.anatomical_structure Myelosarcoma hemic and lymphatic diseases 030220 oncology & carcinogenesis Cancer research Medicine Bone marrow Sarcoma business
Zdroj:	Blood. 131:577-581
ISSN:	1528-0020 0006-4971
DOI:	10.1182/blood-2017-07-793620
Popis:	TO THE EDITOR: Myeloid (or granulocytic) sarcoma (MS), that is, an extramedullary tumor consisting of myeloid blastic cells, is a unique clinical presentation of any type of acute myeloid leukemia (AML), according to the World Health Organization.[1][1] It could present (1) de novo (isolated MS), (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a6c76d8774ae37eb858f31ad39257d78 https://doi.org/10.1182/blood-2017-07-793620 Zobrazit plný text záznamu